Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Kumar

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
Plos One|April 4, 2015
Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosisJose F Camargo, Alyajahan Bhimji, Deepali Kumar, et al.
Transplantation|November 9, 2023
Chronic Active Antibody-mediated Rejection: Opportunity to Determine the Role of Interleukin-6 BlockadeMel Berger, Mary Baliker, Teun Van Gelder, et al.
Transplantation|November 5, 2010
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic responseLuiz F Lisboa, Anders Asberg, Deepali Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2017
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant RecipientsYoichiro Natori, Mika Shiotsuka, Jaclyn Slomovic, et al.
The Lancet. Infectious Diseases|August 14, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to actionJoshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2019
Humoral response to natural influenza infection in solid organ transplant recipientsCedric Hirzel, Victor H Ferreira, Arnaud G L'Huillier, et al.
The Journal of Infectious Diseases|January 16, 2015
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza VaccinationAdrian Egli, Atul Humar, Lukas A Widmer, et al.
Trials|December 22, 2022
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and designPeter W Nickerson, Georg A Böhmig, Steve Chadban, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 29, 2024
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE studyEmily A Blumberg, Oliver Witzke, Mark Harber, et al.
Transplantation|November 28, 2023
SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral StrainTorin Halvorson, Sabine Ivison, Qing Huang, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Plos One|April 4, 2015
Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosisJose F Camargo, Alyajahan Bhimji, Deepali Kumar, et al.
Transplantation|November 9, 2023
Chronic Active Antibody-mediated Rejection: Opportunity to Determine the Role of Interleukin-6 BlockadeMel Berger, Mary Baliker, Teun Van Gelder, et al.
Transplantation|November 5, 2010
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic responseLuiz F Lisboa, Anders Asberg, Deepali Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2017
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant RecipientsYoichiro Natori, Mika Shiotsuka, Jaclyn Slomovic, et al.
The Lancet. Infectious Diseases|August 14, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to actionJoshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2019
Humoral response to natural influenza infection in solid organ transplant recipientsCedric Hirzel, Victor H Ferreira, Arnaud G L'Huillier, et al.
The Journal of Infectious Diseases|January 16, 2015
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza VaccinationAdrian Egli, Atul Humar, Lukas A Widmer, et al.
Trials|December 22, 2022
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and designPeter W Nickerson, Georg A Böhmig, Steve Chadban, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 29, 2024
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE studyEmily A Blumberg, Oliver Witzke, Mark Harber, et al.
Transplantation|November 28, 2023
SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral StrainTorin Halvorson, Sabine Ivison, Qing Huang, et al.
Pageof 24